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Background
One feature of allergic asthma, the early allergic reaction
(EAR), is not present in the commonly used mouse
models. We therefore investigated the mediators
involved in EAR in a guinea pig in vivo model of allergic
airway inflammation.
Method
Animals were sensitized using a single ovalbumin
(OVA)/alum injection and challenged with aerosolized
OVA on day 14. On day 15, airway resistance was
assessed after challenge with OVA or methacholine
using the forced oscillation technique, and lung tissue
was prepared for histology.
Results
The contribution of mast cell mediators was investigated
using histamine 1 receptor (pyrilamine) and cysteinyl
leukotriene 1 receptor (montelukast) antagonists, and
the cyclooxygenase inhibitor indomethacin as single
treatment, or as dual or triple combinations. OVA-sensi-
tized and challenged animals demonstrated airway
hyperresponsiveness to methacholine, and lung tissue
eosinophilic inflammation. Antigen challenge induced a
strong EAR in the sensitized animals. Treatment with a
single compound, or indomethacin together with pyrila-
mine or montelukast, did not reduce the antigen-
induced airway resistance. In contrast, dual treatment
with pyrilamine together with montelukast, or triple
inhibitor treatment, attenuated approximately 70% of
the EAR.
Conclusion
We conclude that, as in humans, the guinea pig allergic
inflammation model exhibit both EAR and airway hyper-
responsiveness, supporting its suitability for in vivo investi-
gations of the effects of mast cell activation with relevance
to asthma. Moreover, the known mast cell mediators his-
tamine and leukotriene caused the main part of the EAR.
The data lend further support to the concept that combi-
nation therapy with selective inhibitors of key mediators
could improve asthma management.
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